• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Bausch + Lomb expands I/A handpieces line

Article

The latest innovation to Bausch + Lomb's Storz ophthalmic instruments, the silicone CapsuleGuard IA line, has expanded from two to ten single-use instruments and provides cataract surgeons with a wider range of options for both incisions and techniques for irrigation and aspiration.

Chicago-The latest innovation to Bausch + Lomb’s Storz ophthalmic instruments, the silicone CapsuleGuard IA line, has expanded from two to ten single-use instruments and provides cataract surgeons with a wider range of options for both incisions and techniques for irrigation/aspiration (I/A).

The line now offers surgeons the smaller, MICS 1.8 incision option, in addition to the standard 2.2 to 2.8 incision ranges. The single-use, silicone instruments also have three new tip designs, allowing surgeons a wider array of techniques for I/A. The line is compatible with Bausch + Lomb’s Stellaris PC Vision Enhancement System, as well as other ophthalmic surgical platforms.

“Our customers and the patients they serve are at the center of every development we bring to market,” said Cal Roberts, MD, executive vice president and chief medical officer, Bausch + Lomb. “This new offering in our signature Storz line was based on direct feedback from the industry’s surgeons who told us they wanted more choices to better treat their cataract surgery patients.”

The Storz CapsuleGuard IA line of instruments was launched in 2010 and features a smooth silicone exterior surface without exposed metal; a flexible tip for use in the removal of peripheral and subincisional cortical material and capsule polishing; and a soft aspiration port that allows for capsule vacuuming for lens epithelial cell removal. The product line is ideal for lens positioning and post-implant viscoelastic removal.

The Storz CapsuleGuard IA line is available in the United States, Australia, Canada, Europe, Hong Kong, India, and Malaysia.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.